The role of B cells in the immunopathogenesis of multiple sclerosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of B cells in the immunopathogenesis of multiple sclerosis
Authors
Keywords
-
Journal
IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-06
DOI
10.1111/imm.13198
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression
- (2019) Tohid Gharibi et al. IMMUNOLOGY LETTERS
- The role of immune regulatory molecules in multiple sclerosis
- (2019) Boshra Afshar et al. JOURNAL OF NEUROIMMUNOLOGY
- Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis
- (2018) Yusei Miyazaki et al. CLINICAL IMMUNOLOGY
- Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis
- (2018) Amit Bar-Or et al. NEUROLOGY
- Effector T Cells in Multiple Sclerosis
- (2018) Belinda J. Kaskow et al. Cold Spring Harbor Perspectives in Medicine
- Clinical Course of Multiple Sclerosis
- (2018) Sylvia Klineova et al. Cold Spring Harbor Perspectives in Medicine
- Regulatory T Cells: From Discovery to Autoimmunity
- (2018) Alexandra Kitz et al. Cold Spring Harbor Perspectives in Medicine
- Multiple Sclerosis Pathology
- (2018) Hans Lassmann Cold Spring Harbor Perspectives in Medicine
- Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity
- (2018) Benjamin Knier et al. NATURE IMMUNOLOGY
- Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses
- (2017) Rui Li et al. JOURNAL OF IMMUNOLOGY
- B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro
- (2017) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis
- (2017) Kathrin Bail et al. Journal of Neuroinflammation
- Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count
- (2017) Erin E Longbrake et al. Multiple Sclerosis Journal
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab
- (2017) David Baker et al. JAMA Neurology
- Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count
- (2017) Erin E Longbrake et al. Multiple Sclerosis Journal
- Dimethyl fumarate alters B-cell memory and cytokine production in MS patients
- (2017) Matthew D. Smith et al. Annals of Clinical and Translational Neurology
- Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen
- (2016) Silke Kinzel et al. ACTA NEUROPATHOLOGICA
- B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responses
- (2016) Judith Fraussen et al. CLINICAL IMMUNOLOGY
- Biological effects of IL-21 on different immune cells and its role in autoimmune diseases
- (2016) Tohid Gharibi et al. IMMUNOBIOLOGY
- Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis
- (2016) Fabiana Rizzo et al. IMMUNOLOGY AND CELL BIOLOGY
- Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis
- (2016) Shiri Blumenfeld et al. JOURNAL OF AUTOIMMUNITY
- Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis
- (2016) Rui Li et al. JOURNAL OF IMMUNOLOGY
- Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins
- (2016) Simone M. Brändle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibodies in multiple sclerosis oligoclonal bands target debris
- (2016) Ryan C. Winger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
- (2016) C. T. Ellebrecht et al. SCIENCE
- Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis
- (2016) Rui Li et al. Frontiers in Immunology
- B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation
- (2016) Kristbjörg Bjarnadóttir et al. Scientific Reports
- Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants
- (2015) Kevin Blauth et al. ACTA NEUROPATHOLOGICA
- B-cell very late antigen-4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity
- (2015) Klaus Lehmann-Horn et al. ANNALS OF NEUROLOGY
- Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis
- (2015) Tohid Gharibi et al. CELLULAR IMMUNOLOGY
- IFN-β and multiple sclerosis: Cross-talking of immune cells and integration of immunoregulatory networks
- (2015) Martina Severa et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index
- (2015) L. de Bock et al. EUROPEAN JOURNAL OF NEUROLOGY
- IFN-β Treatment Requires B Cells for Efficacy in Neuroautoimmunity
- (2015) Ryan D. Schubert et al. JOURNAL OF IMMUNOLOGY
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- The Ins and Outs of B Cells in Multiple Sclerosis
- (2015) Kevin Blauth et al. Frontiers in Immunology
- Immunoglobulin M oligoclonal bands: Biomarker of targetable inflammation in primary progressive multiple sclerosis
- (2014) Luisa M. Villar et al. ANNALS OF NEUROLOGY
- Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation
- (2014) Eduardo Beltrán et al. BRAIN
- Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations
- (2014) Yusei Miyazaki et al. CLINICAL IMMUNOLOGY
- Relapsing and progressive forms of multiple sclerosis
- (2014) Ranjan Dutta et al. CURRENT OPINION IN NEUROLOGY
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- (2014) Amit Bar-Or et al. DRUGS
- Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
- (2014) Masanori Matsumoto et al. IMMUNITY
- Autoantibody Profiling in Multiple Sclerosis Reveals Novel Antigenic Candidates
- (2014) V. Somers et al. JOURNAL OF IMMUNOLOGY
- Sperm-Associated Antigen 16 Is a Novel Target of the Humoral Autoimmune Response in Multiple Sclerosis
- (2014) Laura de Bock et al. JOURNAL OF IMMUNOLOGY
- BAFF Suppresses IL-15 Expression in B Cells
- (2014) N. Ma et al. JOURNAL OF IMMUNOLOGY
- Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis
- (2014) Valeria Studer et al. JOURNAL OF NEUROIMMUNOLOGY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF
- (2014) Clemens Warnke et al. Multiple Sclerosis Journal
- Differential effects of fingolimod on B-cell populations in multiple sclerosis
- (2014) Masakazu Nakamura et al. Multiple Sclerosis Journal
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
- (2014) Ping Shen et al. NATURE
- Interleukin-35 induces regulatory B cells that suppress autoimmune disease
- (2014) Ren-Xi Wang et al. NATURE MEDICINE
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis
- (2014) Yusei Miyazaki et al. PLoS One
- Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
- (2014) A. Palanichamy et al. Science Translational Medicine
- B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
- (2014) J. N. H. Stern et al. Science Translational Medicine
- The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis
- (2014) Sara J. Ireland et al. JAMA Neurology
- Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis
- (2013) J. Sellner et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
- (2013) Nicolas Molnarfi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude
- (2013) R. Dobson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis
- (2013) A. Bar-Or et al. NEUROLOGY
- Increased B Cell and Cytotoxic NK Cell Proportions and Increased T Cell Responsiveness in Blood of Natalizumab-Treated Multiple Sclerosis Patients
- (2013) Johan Mellergård et al. PLoS One
- Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
- (2012) Christina Elliott et al. BRAIN
- B cell exchange across the blood-brain barrier in multiple sclerosis
- (2012) H.-Christian von Büdingen et al. JOURNAL OF CLINICAL INVESTIGATION
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Novel IL-10-Independent Regulatory Role for B Cells in Suppressing Autoimmunity by Maintenance of Regulatory T Cells via GITR Ligand
- (2012) A. Ray et al. JOURNAL OF IMMUNOLOGY
- Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
- (2012) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
- (2012) Ayumi Yoshizaki et al. NATURE
- Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
- (2012) Rajneesh Srivastava et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial
- (2011) R. F. van Vollenhoven et al. ARTHRITIS AND RHEUMATISM
- Glatiramer Acetate in the Treatment of Multiple Sclerosis
- (2011) Patrice H. Lalive et al. CNS DRUGS
- Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis
- (2011) Raquel Planas et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis
- (2011) Kathryn M. Brennan et al. JOURNAL OF NEUROIMMUNOLOGY
- Antibody response in MOG35–55 induced EAE
- (2011) Patrice H. Lalive et al. JOURNAL OF NEUROIMMUNOLOGY
- Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
- (2011) Klaus Lehmann-Horn et al. Journal of Neuroinflammation
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients
- (2011) Felipe von Glehn et al. Multiple Sclerosis Journal
- Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
- (2011) M. C. Kowarik et al. NEUROLOGY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity
- (2010) Martin S. Weber et al. ANNALS OF NEUROLOGY
- A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
- (2010) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- The role of antibodies in multiple sclerosis
- (2010) Martin S. Weber et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
- (2010) Y. Iwata et al. BLOOD
- Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4+ T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein
- (2010) Christopher T. Harp et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
- (2010) Norman Putzki et al. EUROPEAN NEUROLOGY
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis
- (2010) Sakhina Begum-Haque et al. JOURNAL OF NEUROIMMUNOLOGY
- Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate
- (2010) Sakhina Begum-Haque et al. JOURNAL OF NEUROIMMUNOLOGY
- Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
- (2010) Daniel Wynn et al. LANCET NEUROLOGY
- Mitoxantrone treatment in multiple sclerosis induces TH2-type cytokines
- (2009) A. Vogelgesang et al. ACTA NEUROLOGICA SCANDINAVICA
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- The prognostic significance of cerebrospinal fluid in multiple sclerosis
- (2009) Sasitorn Siritho et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Memory and naïve B-cell subsets in patients with multiple sclerosis
- (2009) Masaaki Niino et al. NEUROSCIENCE LETTERS
- Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals
- (2009) T. Derfuss et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Helminth infections associated with multiple sclerosis induce regulatory B cells
- (2008) Jorge Correale et al. ANNALS OF NEUROLOGY
- Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
- (2008) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis
- (2008) Christopher T. Harp et al. CLINICAL IMMUNOLOGY
- Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis
- (2008) Birgit Obermeier et al. NATURE MEDICINE
- Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
- (2008) M. Krumbholz et al. NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells
- (2008) T. Korn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started